• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碱基编辑和先导编辑在人造血干细胞中的遗传毒性效应。

Genotoxic effects of base and prime editing in human hematopoietic stem cells.

机构信息

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Vita-Salute San Raffaele University, Milan, Italy.

出版信息

Nat Biotechnol. 2024 Jun;42(6):877-891. doi: 10.1038/s41587-023-01915-4. Epub 2023 Sep 7.

DOI:10.1038/s41587-023-01915-4
PMID:37679541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11180610/
Abstract

Base and prime editors (BEs and PEs) may provide more precise genetic engineering than nuclease-based approaches because they bypass the dependence on DNA double-strand breaks. However, little is known about their cellular responses and genotoxicity. Here, we compared state-of-the-art BEs and PEs and Cas9 in human hematopoietic stem and progenitor cells with respect to editing efficiency, cytotoxicity, transcriptomic changes and on-target and genome-wide genotoxicity. BEs and PEs induced detrimental transcriptional responses that reduced editing efficiency and hematopoietic repopulation in xenotransplants and also generated DNA double-strand breaks and genotoxic byproducts, including deletions and translocations, at a lower frequency than Cas9. These effects were strongest for cytidine BEs due to suboptimal inhibition of base excision repair and were mitigated by tailoring delivery timing and editor expression through optimized mRNA design. However, BEs altered the mutational landscape of hematopoietic stem and progenitor cells across the genome by increasing the load and relative proportions of nucleotide variants. These findings raise concerns about the genotoxicity of BEs and PEs and warrant further investigation in view of their clinical application.

摘要

碱基编辑和先导编辑(BEs 和 PEs)可能比基于核酸酶的方法提供更精确的基因工程,因为它们绕过了对 DNA 双链断裂的依赖。然而,关于它们的细胞反应和遗传毒性知之甚少。在这里,我们比较了最先进的 BEs 和 PEs 以及 Cas9 在人造血干细胞和祖细胞中的编辑效率、细胞毒性、转录组变化以及靶向和全基因组遗传毒性。BEs 和 PEs 诱导了有害的转录反应,降低了编辑效率和异种移植中的造血重建效率,并且以低于 Cas9 的频率产生 DNA 双链断裂和遗传毒性副产物,包括缺失和易位。由于碱基切除修复的抑制作用不理想,胞嘧啶 BEs 的这些作用最强,并通过优化 mRNA 设计来调整递送时间和编辑表达来减轻。然而,BEs 通过增加核苷酸变异的负荷和相对比例来改变造血干细胞和祖细胞的突变景观。这些发现引起了对 BEs 和 PEs 的遗传毒性的关注,并鉴于其临床应用需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/54d2a86bdc71/41587_2023_1915_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/0b2fc6c1d4e8/41587_2023_1915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/b69dd3ba5fc9/41587_2023_1915_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/5736b2875950/41587_2023_1915_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/f03cb96c19b5/41587_2023_1915_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/b62a8e8baede/41587_2023_1915_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/db03115b5442/41587_2023_1915_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/f8349c9e1681/41587_2023_1915_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/45f965a4f9b0/41587_2023_1915_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/fdc8ecb65c15/41587_2023_1915_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/6d4e9dacdfa7/41587_2023_1915_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/54d2a86bdc71/41587_2023_1915_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/0b2fc6c1d4e8/41587_2023_1915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/b69dd3ba5fc9/41587_2023_1915_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/5736b2875950/41587_2023_1915_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/f03cb96c19b5/41587_2023_1915_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/b62a8e8baede/41587_2023_1915_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/db03115b5442/41587_2023_1915_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/f8349c9e1681/41587_2023_1915_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/45f965a4f9b0/41587_2023_1915_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/fdc8ecb65c15/41587_2023_1915_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/6d4e9dacdfa7/41587_2023_1915_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df64/11180610/54d2a86bdc71/41587_2023_1915_Fig11_ESM.jpg

相似文献

1
Genotoxic effects of base and prime editing in human hematopoietic stem cells.碱基编辑和先导编辑在人造血干细胞中的遗传毒性效应。
Nat Biotechnol. 2024 Jun;42(6):877-891. doi: 10.1038/s41587-023-01915-4. Epub 2023 Sep 7.
2
A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells.一种用于定量分析人类造血细胞系和造血干/祖细胞中 CRISPR/Cas9 诱导基因组编辑事件的多功能工具。
J Mol Biol. 2019 Jan 4;431(1):102-110. doi: 10.1016/j.jmb.2018.05.005. Epub 2018 May 9.
3
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.NHEJ 介导的 CRISPR-Cas9 诱导的 DNA 断裂修复可有效纠正范可尼贫血患者造血干细胞中的突变。
Cell Stem Cell. 2019 Nov 7;25(5):607-621.e7. doi: 10.1016/j.stem.2019.08.016. Epub 2019 Sep 19.
4
In vivo somatic cell base editing and prime editing.体内体细胞碱基编辑和先导编辑。
Mol Ther. 2021 Nov 3;29(11):3107-3124. doi: 10.1016/j.ymthe.2021.09.002. Epub 2021 Sep 10.
5
Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.通过 CRISPR-Cas9 介导的非同源性靶向整合在人造血干/祖细胞中进行基因组编辑。
Mol Ther. 2021 Apr 7;29(4):1611-1624. doi: 10.1016/j.ymthe.2020.12.010. Epub 2020 Dec 10.
6
Genotoxicity concerns for base and prime editors in hematopoietic stem cells.造血干细胞中碱基编辑器和引导编辑器的遗传毒性问题。
Nat Biotechnol. 2024 Jun;42(6):850-851. doi: 10.1038/s41587-023-01916-3.
7
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response.精确的基因编辑可保留短暂的 p53 介导的 DNA 损伤反应后造血干细胞的功能。
Cell Stem Cell. 2019 Apr 4;24(4):551-565.e8. doi: 10.1016/j.stem.2019.02.019. Epub 2019 Mar 21.
8
Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases.碱基编辑介导的造血干细胞基因治疗血液系统疾病。
Stem Cell Rev Rep. 2024 Aug;20(6):1387-1405. doi: 10.1007/s12015-024-10715-5. Epub 2024 Apr 22.
9
Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.利用CRISPR碱基编辑器和引导编辑器的mRNA在人诱导多能干细胞中高效产生和纠正突变
Genes (Basel). 2020 May 6;11(5):511. doi: 10.3390/genes11050511.
10
Plant base editing and prime editing: The current status and future perspectives.植物碱基编辑和引导编辑:现状与未来展望。
J Integr Plant Biol. 2023 Feb;65(2):444-467. doi: 10.1111/jipb.13425. Epub 2023 Feb 15.

引用本文的文献

1
An integrated enzymatic and computational pipeline for quantifying off-target base-editing.一种用于量化脱靶碱基编辑的集成酶促和计算流程。
bioRxiv. 2025 Aug 26:2025.08.26.667396. doi: 10.1101/2025.08.26.667396.
2
CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome.用于T细胞的CRISPR工具:靶向基因组、表观基因组和转录组。
Trends Cancer. 2025 Aug 28. doi: 10.1016/j.trecan.2025.08.001.
3
Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins.通过瞬时递送CRISPR表观基因组编辑器核糖核蛋白进行可编程表观基因组编辑。

本文引用的文献

1
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy.基因工程与造血干细胞生物学相遇,开启下一代基因治疗的新篇章。
Cell Stem Cell. 2023 May 4;30(5):549-570. doi: 10.1016/j.stem.2023.04.014.
2
Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice.在体预编辑患者造血干细胞可在移植入小鼠后挽救镰状细胞病表型。
Nat Biomed Eng. 2023 May;7(5):616-628. doi: 10.1038/s41551-023-01026-0. Epub 2023 Apr 17.
3
Predicting prime editing efficiency and product purity by deep learning.
Nat Commun. 2025 Aug 26;16(1):7948. doi: 10.1038/s41467-025-63167-x.
4
ONE-STEP tagging: a versatile method for rapid site-specific integration by simultaneous reagent delivery.一步标记法:一种通过同时递送试剂实现快速位点特异性整合的通用方法。
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf809.
5
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.靶向基因编辑以及CYBA和CYBB的近乎普遍的cDNA插入作为慢性肉芽肿病的一种治疗方法。
Nat Commun. 2025 Aug 12;16(1):7475. doi: 10.1038/s41467-025-62738-2.
6
Beyond the Cut: Long-read sequencing reveals complex genomic and transcriptomic changes in AAV-CRISPR therapy for Duchenne Muscular Dystrophy.深入剖析:长读长测序揭示了腺相关病毒介导的CRISPR疗法治疗杜氏肌营养不良症时复杂的基因组和转录组变化
bioRxiv. 2025 Aug 1:2025.08.01.668007. doi: 10.1101/2025.08.01.668007.
7
The hidden risks of CRISPR/Cas: structural variations and genome integrity.CRISPR/Cas的潜在风险:结构变异与基因组完整性
Nat Commun. 2025 Aug 5;16(1):7208. doi: 10.1038/s41467-025-62606-z.
8
A side-by-side comparison of variant function measurements using deep mutational scanning and base editing.使用深度突变扫描和碱基编辑对变异功能测量进行的并列比较。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf738.
9
precision base editing to rescue mouse models of disease.用于拯救疾病小鼠模型的精准碱基编辑
Mol Ther Nucleic Acids. 2025 Jul 1;36(3):102622. doi: 10.1016/j.omtn.2025.102622. eCollection 2025 Sep 9.
10
CRISPR-based therapeutic genome editing for inherited blood disorders.基于CRISPR的遗传性血液疾病治疗性基因组编辑
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01236-y.
通过深度学习预测 Prime Editing 的效率和产物纯度。
Nat Biotechnol. 2023 Aug;41(8):1151-1159. doi: 10.1038/s41587-022-01613-7. Epub 2023 Jan 16.
4
Improved cytosine base editors generated from TadA variants.经 TadA 变体改造的改良胞嘧啶碱基编辑器。
Nat Biotechnol. 2023 May;41(5):686-697. doi: 10.1038/s41587-022-01611-9. Epub 2023 Jan 9.
5
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity.腺嘌呤碱基编辑器演变为具有低脱靶活性的小而高效的胞嘧啶碱基编辑器。
Nat Biotechnol. 2023 May;41(5):673-685. doi: 10.1038/s41587-022-01533-6. Epub 2022 Nov 10.
6
Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing.全面分析和准确量化 CRISPR-Cas9 基因编辑诱导的非预期大基因修饰。
Sci Adv. 2022 Oct 21;8(42):eabo7676. doi: 10.1126/sciadv.abo7676.
7
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.模板递送方式的选择可减轻基因编辑对人造血干细胞的遗传毒性风险和不良影响。
Cell Stem Cell. 2022 Oct 6;29(10):1428-1444.e9. doi: 10.1016/j.stem.2022.09.001.
8
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.基于动员的基因编辑人造血干细胞无化疗植入。
Cell. 2022 Jun 23;185(13):2248-2264.e21. doi: 10.1016/j.cell.2022.04.039. Epub 2022 May 25.
9
Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair.在不存在错配修复的情况下,碱基编辑的效率和保真度得到提高。
Nat Commun. 2022 Feb 9;13(1):760. doi: 10.1038/s41467-022-28442-1.
10
Base and Prime Editing Technologies for Blood Disorders.用于血液疾病的碱基编辑和引导编辑技术。
Front Genome Ed. 2021 Jan 28;3:618406. doi: 10.3389/fgeed.2021.618406. eCollection 2021.